Respectful Insolence

As a followup to my rather “epic post” on dichloroacetate, I thought I’d just post a brief follow up. A reader sent me this video of Evangelos Michelakis, the investigator who has been testing DCA in the clinic and who did the study testing DCA against gliblastoma, describing his results:

It’s always interesting to hear research results “straigh from the horse’s mouth, so to speak.”

Comments

  1. #1 bob smith
    May 19, 2010

    Try DCA with Metformin the diabetes pill, or better yet, the I.V. version.

  2. #2 DaveScot
    May 21, 2010

    Well I’m glad these guys put to rest the notion that compounds in the public domain which are discovered to be useful in the fight against cancer can be brought to market without industry support.

    I mean, no one here has any doubt that if Pfizer had been able to patent DCA three years ago we would be at exactly the same point in the process of bringing it to the cancer patients who need it. Pfizer would have limited internal funding of clinical trials to $500,000 per year, right? And of course, out of the goodness of their hearts, given it’s about as difficult to make as iodized table salt, they would have sold it for pennies per daily dose.

    Uh huh. That’s how it would have played out…

  3. #3 Antaeus Feldspar
    May 27, 2010

    What? What’s that, DaveScot? I can’t hear you over the sound of goalposts being hastily dragged.

  4. #4 bob smith
    April 7, 2011

    Now that oracle has at least reason to doubt his on misdirected and wrongly negative pontifications, how about considering Metformin, another generic shown to act against cancer’s metabolism,, along with DCA ?? Two attacks on cancer’s metabolism ,, 1+1 might equal 100. At least please try a rodent trial !! Both would slow/act against cancers glycolysis , they would seem very likely candidates to be considered for use together. If not, then why not?

  5. #5 Pispirigos Kyriakos PhD
    July 5, 2011

    CLINICAL BIOCHEMISTRY RESEARCH CENTER
    DIRECTOR:PROF:KYRIAKOS PISPIRIGOS

    Dear Eyaggelos,

    We would like to informing you that, the compound Dichloroacetate (DCA), we have been working and the evaluation for the subacute toxicity results, concerns
    Cardio-Liver and kidney results.
    In case you are interest, please give a call, OK?

    Best Regards

    Kyriakos Pispirigos PhD

  6. #6 Pispirigos Kyriakos PhD
    July 5, 2011

    CLINICAL BIOCHEMISTRY RESEARCH CENTER
    DIRECTOR:PROF:KYRIAKOS PISPIRIGOS

    Dear Eyaggelos,

    We would like to informing you that, the compound Dichloroacetate (DCA), we have been working and the evaluation for the subacute toxicity results, concerns
    Cardio-Liver and kidney results.
    In case you are interest, please give a call, +302610273277 OK?

    Best Regards

    Kyriakos Pispirigos PhD

The site is undergoing maintenance presently. Commenting has been disabled. Please check back later!